Respiratory syncytial virus uses a Vps4-independent budding mechanism controlled by Rab11-FIP2

Respiratory syncytial virus (RSV) infects polarized epithelia, which have tightly regulated trafficking because of the separation and maintenance of the apical and basolateral membranes. Previously we established a link between the apical recycling endosome (ARE) and the assembly of RSV. The current...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 105; no. 29; pp. 10209 - 10214
Main Authors Utley, Thomas J, Ducharme, Nicole A, Varthakavi, Vasundhara, Shepherd, Bryan E, Santangelo, Philip J, Lindquist, Michael E, Goldenring, James R, Crowe, James E. Jr
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 22.07.2008
National Acad Sciences
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Respiratory syncytial virus (RSV) infects polarized epithelia, which have tightly regulated trafficking because of the separation and maintenance of the apical and basolateral membranes. Previously we established a link between the apical recycling endosome (ARE) and the assembly of RSV. The current studies tested the role of a major ARE-associated protein, Rab11 family interacting protein 2 (FIP2) in the virus life cycle. A dominant-negative form of FIP2 lacking its N-terminal C2 domain reduced the supernatant-associated RSV titer 1,000-fold and also caused the cell-associated virus titer to increase. These data suggested that the FIP2 C2 mutant caused a failure at the final budding step in the virus life cycle. Additionally, truncation of the Rab-binding domain from FIP2 caused its accumulation into mature filamentous virions. RSV budding was independent of the ESCRT machinery, the only well-defined budding mechanism for enveloped RNA viruses. Therefore, RSV uses a virus budding mechanism that is controlled by FIP2.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Author contributions: T.J.U., J.R.G., and J.E.C. designed research; T.J.U. and V.V. performed research; T.J.U., N.A.D., P.J.S., and M.E.L. contributed new reagents/analytic tools; T.J.U., V.V., B.E.S., J.R.G., and J.E.C. analyzed data; and T.J.U. and J.E.C. wrote the paper.
Edited by Peter Palese, Mount Sinai School of Medicine, New York, NY, and approved May 8, 2008
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.0712144105